Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neutrophil extracellular traps promote liver metastasis by impairing NK cell-dependent tumor surveillance via CCDC25. | Nat Commun | 2026 | 42716934 | PubTator, text mining | PubMed |
| Interleukin-37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence-Free Survival in Hepatocellular Carcinoma Patients. | J Hepatobiliary Pancreat Sci | 2026 | 42695172 | PubTator, text mining | PubMed |
| Friend or foe: divergent immunomodulatory effects of metabolites derived from the virucidal zinc finger inhibitor SAMT-247. | Front Immunol | 2026 | 42694244 | PubTator, text mining | PubMed |
| NKp44 recognition of platelet-derived growth factor D enhances the cytolytic activity of natural killer cells. | J Immunol | 2026 | 42522261 | PubTator, text mining | PubMed |
| Coexpression of GITRL confers resistance to Treg cell-mediated immunosuppression to anti-CD19 CAR-NK cells. | Front Immunol | 2026 | 42488650 | PubTator, text mining | PubMed |
| Transcriptomic profiling of autoimmune hepatitis identifies TRAT1 as an in vitro negative regulator of NK cell effector functions. | Front Immunol | 2026 | 42483202 | PubTator, text mining | PubMed |
| Exploring the cognitive effects of arthritis: A Mendelian randomization study and cross-sectional analysis of NHANES data. | Medicine (Baltimore) | 2026 | 42470017 | PubTator, text mining | PubMed |
| Uncovering the cytogenetic hallmarks of resident and expanded natural killer cells from patients with acquired aplastic anemia. | Sci Rep | 2026 | 42448949 | PubTator, text mining | PubMed |
| Role of Innate Lymphoid Cells in Chronic Rhinosinusitis: Insights from Tissue and Peripheral Blood Flow Cytometric Analysis. | Adv Respir Med | 2026 | 42345640 | PubTator, text mining | PubMed |
| Sustained mucosal delivery of SAMT-247 via an intravaginal ring reduces the risk of SIVmac251 acquisition in vaccinated macaques. | Cell Rep Med | 2026 | 42302793 | PubTator, text mining | PubMed |
| Natural killer cells in pediatric HIV cure strategies: from viral control to immunotherapeutics. | Curr Opin HIV AIDS | 2026 | 42139144 | PubTator, text mining | PubMed |
| The role of DAP12 in immune-related inflammatory diseases. | Inflamm Res | 2026 | 42089995 | PubTator, text mining | PubMed |
| Transcriptional Profile Change of NK-92 Cells in Presence of Cytokines, TGFβ Signaling Pathway Inhibitor and CDK7/12/13 Kinase Inhibitor. | Int J Mol Sci | 2026 | 42074237 | PubTator, text mining | PubMed |
| The NKp44-1 Isoform Is an Activating Receptor for PDGF-DD Expressed on Natural Killer Cells. | Cancers (Basel) | 2026 | 41976321 | PubTator, text mining | PubMed |
| Abnormal expression of ILT2, NKG2D and NKp46 receptors on natural killer cells in women with unexplained recurrent implantation failure. | J Reprod Immunol | 2026 | 41950815 | PubTator, text mining | PubMed |
| HLA Class II Protein Expression Regulation Is Strongly Linked to Cis-Acting SNPs. | HLA | 2026 | 41937692 | PubTator, text mining | PubMed |
| IDH1 Mutant Glioma Favors Group 3 Innate Lymphoid Cells and Is Resistant to Immune Checkpoint Expression. | Inflamm Res | 2026 | 41917320 | PubTator, text mining | PubMed |
| Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial. | Cancer Immunol Immunother | 2026 | 41915180 | PubTator, text mining | PubMed |
| Tumor-infiltrating immature innate lymphoid cells in colorectal cancer are biased toward ILC1/tissue-resident NK cell differentiation. | Nat Commun | 2026 | 41896575 | PubTator, text mining | PubMed |
| Re-Tooling of γδ T Cells for Cancer Immunotherapy Using Advanced Manufacturing and Genetic Engineering. | Cells | 2026 | 41892285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers